Watch For Drug Interactions on Patients Taking the Viekira Ribavirin Combo

February 2015

You'll see yet another new ORAL combo hepatitis C regimen...Viekira Pak (ombitasvir/paritaprevir/ritonavir and dasabuvir).

Treatment of hepatitis C is evolving fast.

Interferon use is dropping...boceprevir (Victrelis) is being discontinued...and telaprevir (Incivek) is already off the market.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote